Abstract
Melatonin is a natural health product used for sleep disturbances. In preliminary studies of adults with advanced cancer, 20 mg of melatonin daily was associated with reduction in anorexia and weight loss-symptoms that also impact pediatric oncology patients. High doses of melatonin have not been studied in pediatrics. This was a multicenter single-arm phase I dose-escalation study utilizing a 3 + 3 design to determine the safety and tolerability of escalating doses of melatonin in pediatric oncology patients with relapsed solid tumors. Melatonin was given for 8 weeks at three dose levels-0.075 mg/kg (maximum 5 mg), 0.15 mg/kg (maximum 10 mg), and 0.3 mg/kg (maximum 20 mg). Melatonin was well tolerated at all three dose levels with no significant adverse events or dose-limiting toxicities. The only grade 3/4 toxicities were myelosuppression, which was attributed to the concomitant chemotherapy and occurred at all dose levels. Weight gain occurred in seven of nine patients, with a median increase of 1.1 kg (range -3.3 to 4.5) or 3.4% (range -10.2 to 8.7), with two patients losing weight (one in dose level 1 and one level 3). Melatonin is well tolerated at a dose of 0.3 mg/kg (maximum 20 mg), in the pediatric population. This stu...Continue Reading
References
Jul 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P LissoniV Chatikhine
Jan 16, 1997·The New England Journal of Medicine·A Brzezinski
Apr 3, 1997·The New England Journal of Medicine·W L DiR Silman
Oct 12, 1999·JAMA : the Journal of the American Medical Association·G S BirketvedtA Stunkard
Mar 23, 2000·Brain Research·V Raghavendra, S K Kulkarni
Nov 9, 2000·Journal of Pineal Research·M L SeabraS Tufik
Jan 6, 2001·Frontiers in Neuroendocrinology·C PacchierottiP Castrogiovanni
Feb 28, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P Lissoni
Jan 24, 2004·Neuro-Signals·Daniel P Cardinali, Ana I Esquifino
Feb 3, 2004·Carcinogenesis·David E BlaskJean A Krause
Nov 25, 2004·The Journal of Clinical Endocrinology and Metabolism·Antonio Carrillo-VicoJuan M Guerrero
Feb 3, 2005·Journal of Pineal Research·Samuel CosEmilio J Sánchez-Barceló
Feb 23, 2005·Nutrition·Christina PerssonPeter Nygren
Sep 13, 2005·Nutrition & Metabolism·Rüdiger Hardeland, S R Pandi-Perumal
Oct 7, 2005·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Elena J LadasPaul Rogers
Feb 24, 2010·Computer Methods and Programs in Biomedicine·Yong ZhangShaofei Xie
May 8, 2010·Journal of Pineal Research·Shi-Young ParkYung-Jin Kim
Feb 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Egidio Del FabbroEduardo Bruera
May 27, 2015·European Journal of Clinical Pharmacology·Nathja Groth HarpsøeJacob Rosenberg
Feb 20, 2016·BMC Pharmacology & Toxicology·Lars P H AndersenIsmail Gögenur
Aug 28, 2016·Clinical Drug Investigation·Nathja Groth HarpsøeJacob Rosenberg
Dec 2, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia CarloniGiuseppe Buonocore